Analytical Testing Capabilities
With extensive GxP experience and advanced analytical platforms, Samsung Biologics provides comprehensive testing services across the entire process — from raw materials to final drug product. All testing, including method transfer, validation, and qualification, is conducted in full compliance with ICH Q2(R1), FDA, EMA, PDMA and other relevant guidelines, ensuring reliable and consistent results that support on-time batch release.
  • Raw material
  • In-process control
  • Release
  • Stability study
  • Validation
  • Environmental
    monitoring
  • IPC & Release Testing
    Our QC team performs critical In-Process Control (IPC) and Drug Substance/Drug Product (DS/DP) Release Testing to ensure product quality and regulatory compliance throughout the manufacturing process.
    We offer a full range of
    analytical services including:
    • Compendial Testing
    • Protein Concentration
    • Titer
    • N-glycan Profile
    • Identification Test (Peptide Mapping / iCIEF)
    • Flow Cytometry
    • Bioassay
    • Purity
    • CE-SDS (Reduced / Non-reduced)
    • Residual Host Cell DNA (qPCR)
    • Residual Host Cell Protein (ELISA)
    • Residual Protein A (ELISA)
    • Potency (Binding ELISA)
    • Sterility
    • Endotoxin
    • Bioburden
  • Stability Study & Testing
    We maintain controlled areas that have validated and monitored stability chambers suitable for the generation of GMP Drug Substance/Drug Product stability data. Physical and kinetic stability profiles are generated with real-time storage conditions, accelerated conditions, and stressed conditions (with temperature/humidity and/or light), in full compliance with ICH guidelines.
    Our stability testing includes:
    • Stability study under ICH conditions (real-time, accelerated, stressed)
    • Potency (ELISA, Bioassay)
    • Endotoxin
    • Bioburden
    • Sterility
  • Environmental Monitoring
    Through our routine testing of facility-related samples (environmental monitoring, water systems, clean steam, clean gas, etc.), we ensure that our controlled environments are maintained for the manufacturing of high-quality products.
    Our environmental monitoring
    includes testing of:
    Environmental Monitoring includes testing for:
    • Viable/Non-viable air particles
    • Surface Monitoring
    Clean Utilities Monitoring includes testing of:
    • Water System
    • Clean Steam
    • Compressed Gases
  • Biosafety Testing
    Samsung Biologics provides ‘End-to-End’ biosafety testing services for CMO / CDO clients. Our analytical services span development-phase testing to GMP lot release testing, including mycoplasma and virus detection assays.
    We also offer expanded
    services such as:
    • Mycoplasma Testing
    • In Vitro Adventitious Virus Assay
    • MVM DNA Detection

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION